Skip to content
Tuesday 11 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,844.19
-0.17%
DAX
26,391.42
+0.26%
CAC 40
8,714.94
-0.13%
STOXX 50
6,551.22
+0.24%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Wednesday 03 September 2014 5:33 pm  |  Updated:  Friday 07 June 2019 6:32 am

Ebola diagnosis sped up with Japan’s 30-minute “sampler” test

By: Sarah Spickernell

Add as a preferred source on Google

Scientists in Japan have developed a test for Ebola which is much faster than any current diagnosis methods. 
 
Researchers at Nagasaki University worked alongside Eiken Chemical Co to develop the new testing method, which they say uses cheaper and faster technology than anything available already.
 
As a result, they claim it can be used in places without an adequate power supply because it is conducted using a “small, battery-powered warmer.” By comparison, the tests currently used for diagnosis require “dedicated equipment and a stable supply of electricity.”
 
The new technique works by using a strand of DNA called a “primer” to magnify Ebola genes in a blood sample taken from a patient. It takes just 30 minutes to determine whether or not they have contracted Ebola.
 
The Polymerase Chain Reacrion (PRC) technique most widely used to test for the virus takes two hours to come to such a conclusion. This is because the full process involves heating and cooling the blood samples a number of times.
 
"The new method is simpler than the current one and can be used in countries where expensive testing equipment is not available," said Jiro Yasuda, a professor at Nagasaki University.
 
"We have yet to receive any questions or requests, but we are pleased to offer the system, which is ready to go.”
 
The Ebola epidemic currently spreading through West Africa began in Guinea in February. It has since spread to Liberia, Sierra Leone and Nigeria. Last week Senegal reported its first confirmed case.
 
By 26 August, there had been 1,752 confirmed cases and 897 confirmed deaths. As you can see from the chart below, Sierra Leone and Liberia have been hit the hardest.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Ebola

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Hargreaves Lansdown orders staff back to office

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • Neurodiversity, employment law and ‘reasonable adjustments’ – the new HR headache

    Law
    Four brown puppies playing on a green mat with pink toys and a paw-print blanket.
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • This Is the Moment Everything Changed: Ascensia Launches Global Art and Photography Competition for World Diabetes Day

    Business Wire
  • Surely Gary Stevenson is smart enough to know a wealth tax won’t work?

    Opinion
    Gary Stevenson speaking at a Patriotic Millionaires event, addressing wealth inequality and economic reform proposals.
  • The seven growth tests every Budget must pass

    Opinion
    Chancellor holding iconic red budget box outside Downing Street, symbolizing UKs annual budget announcement
  • Vance says ‘broken’ Britain must rebuild economy, not just change PM

    Politics
    Andy Burnham returns to Parliament
  • Eaton Opens European Aerospace Additive Manufacturing Center to Expand Production and Strengthen Regional Supply Chain Resilience

    Business Wire
  • VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook